Opioid-Induced Constipation (OIC) Treatment Market

Future Market Insights

Key Insight

The opioid-induced constipation (oic) treatment market is projected to grow from USD 2.9 billion in 2025 to USD 4.5 billion by 2035, at a CAGR of 4.6%. Naloxegol will dominate with a 36.7% market share, while oral will lead the method of administration segment with a 61.3% share.

September 12, 2025

Anurag Sharma

250 Pages

Cite this Report

Opioid-Induced Constipation (OIC) Treatment Market

https://www.futuremarketinsights.com/reports/opioid-induced-constipation-oic-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

Allergan (Ireland)
Daiichi Sankyo Company
Ironwood Pharmaceuticals
Mundipharma International Limited
Nektar Therapeutics
The Vanguard Group
Progenics Pharmaceuticals
Purdue Pharma
S.L.A. Pharma
Shionogi & Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Opioid-Induced Constipation (OIC) Treatment Market

Key Players

Similar Industry Reports